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Background: To be less resource intensive, we developed a template-based breast IMRT technique (TB-IMRT). This
study aims to compare resources and dose distribution between TB-IMRT and conventional breast radiation (CBR).
Methods: Twenty patients with early stage breast cancer were planned using CBR and TB-IMRT. Time to plan,
coverage of volumes, dose to critical structures and treatment times were evaluated for CBR and TB-IMRT. Two
sided-paired t tests were used.
Results: TB-IMRT planning time was less than CBR (14.0 vs 39.0 min, p < 0.001). Fifteen patients with CBR needed
18 MV, and 11 of these were planned successfully with TB-IMRT using 6 MV. TB-IMRT provided better homogeneity
index (0.096 vs 0.124, p < 0.001) and conformity index (0.68 vs 0.59, p = 0.003). Dose to critical structures were
comparable between TB-IMRT and CBR, and treatment times were also similar (6.0 vs 7.8 min, p = 0.13).
Conclusions: TB- IMRT provides reduction of planning time and minimizes the use of high energy beams, while
providing similar treatment times and equal plans compared to CBR. This technique permits efficient use of
resources with a low learning curve, and can be done with existing equipment and personnel.
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Breast cancer is the most common invasive female can-
cer in North America and early stage disease comprises
the majority of cases. Radiation is a crucial component
of therapy for women with early stage breast cancer.
With the advent of breast conservation therapy, breast
cancer patients can now preserve the breast with the
same survival outcomes as modified radical mastectomy.
Radiation reduces breast cancer recurrence rates by two-
thirds, with an associated survival benefit as well [1,2].
Radiation practice has shifted from two-dimensional
therapy based on conventional simulator and anatomical
landmarks to a three-dimensional approach using CT
planning. Radiation advances have made way for breast
intensity modulated radiation therapy (IMRT) to further
improve the planning process and delivery of radiation.
Early data has shown that IMRT can achieve a more* Correspondence: sonia_nguyen_7@hotmail.com
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reproduction in any medium, provided the orhomogeneous dose distribution while delivering less
dose to normal tissue [3-5], which has translated into a
reduction of side effects [6,7]. Over recent years, the use
of breast IMRT has been increasing, at least in the
United States [8] and large academic centers [6].
Nevertheless, conventional breast radiation (CBR) is
still used in a larger percentage of radiation treatment
facilities in North America and Europe in lieu of breast
IMRT [9]. While the utility of IMRT is particularly evi-
dent when target volumes have complex shapes, or are
near organs at risk, the homogeneity and toxicity advan-
tages of IMRT for the breast have to be weighed against
workload impact. Conventional tangential beams that
deliver radiation to the whole breast remain simple and
effective. In view of possible limited clinical resources
and time constraints, newer radiation planning tech-
niques such as IMRT may burden the health care sys-
tem. This is particularly true in the setting of adjuvant
breast radiation, which represents a sizeable part of a ra-
diation department’s practice.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Portions of underlying critical organs (lung and liver
for right-sided tumors and lung and heart for left-sided
tumors) overlapping the posterior border of the tangents were
contoured as structures to be excluded from the TVeval.
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the impact of breast IMRT on cost and logistic issues
needs to be ascertained. In order to suit the Canadian
environment, we developed a template-based inverse
optimization breast IMRT technique (TB-IMRT) to
achieve the advantages of breast IMRT without being re-
source intensive. The purpose of this study is to com-
pare efficiency of resources between CBR and breast
TB-IMRT and to compare dose distributions between
CBR and TB-IMRT to validate our technique.
Methods
Patients
Twenty patients (6 with right-sided and 14 with left-sided
tumors) who had been previously treated with adjuvant ex-
ternal beam radiation therapy to the whole breast at the
Fraser Valley Cancer Centre were randomly selected. They
had either stage T1 or T2 breast cancer and had undergone
breast conserving surgery. All patients had sentinel node
biopsy and/or axillary nodal dissection. Chemotherapy,
endocrine therapy and trastuzumab were given when indi-
cated. Actual treatments for all 20 cases were carried out
with CBR plans. Plans were then carried out retrospec-
tively using the TB-IMRT technique for this same group
of patients. Dose-fractionation varied from 42.5 Gy in 16
fractions (2.66 Gy per fraction) to 50 Gy in 25 fractions
(2 Gy per fraction), given once per day, 5 days a week.
Study approval was obtained from the University of British
Columbia/B.C. Cancer Agency Institutional Review Board.
Structure contouring for TB-IMRT and CBR
All patients had a simulation-CT scan performed in treat-
ment position. All patients were supine with both arms
extended above their head in a Vac-Lok™ cushion. A
Civco MT-350 carbon fiber breast board with angles ran-
ging from 5 to 20° from the couch was used. The surgical
scar and clinical breast tissue was demarcated with a
radio-opaque wire. Imaging was performed with a Philips
Scanner (Brilliance CT, Big Bore, Philips, Cleveland, OH),
and acquired in 2 mm slices from 6 cm superior to the
clavicle to 8 cm inferior to breast tissue. CT images were
exported to the treatment planning system, Eclipse ver-
sion 10.0.28 (Varian Medical Systems, Palo Alto, CA).
When the patient’s planning CT is imported into the
Eclipse software, a body contour is generated, edited and
post processed according to local procedure.
At our institution, the radiation oncologist adjusts
beam placement based on the clinical borders of the
breast volume using the radio-opaque markers placed in
CT as well as the location of the lumpectomy cavity on
simulation-CT. This was done for CBR and TB-IMRT.
Typically the medial treatment beam entry point is at
midline, the lateral beam is 2 cm posterior to palpable
breast tissue, the superior limit of the beam is at or upto 1 cm below the suprasternal notch, and the inferior
limit of the beam is 2 cm below palpable breast. The
beam angles were thus selected by the treating radiation
oncologist and were patient-dependent. The breast
treated volume (TV) used for plan evaluation (TVeval)
was defined with the aid of these tangential fields. The
breast treated volume was thus defined as the volume
encompassed by the tangential fields, placed by the radi-
ation oncologist. In order to create a breast TVeval, por-
tions of underlying critical organs (lung and liver for
right-sided tumors and lung and heart for left-sided
tumors) overlapping the posterior border of the tangents
were contoured as structures to be excluded from the
TVeval (Figure 1). The breast TVeval was delineated as
1.5 cm inside the superior and inferior field borders and
5 mm from the skin surface (using the body contour),
lung, liver and/or heart. Lung, liver and heart contours
were usually done to define the TV only and not used for
dose reporting. The lung contours were created with an
automatic tool in the Eclipse software and the heart or
liver were contoured only in regions overlapping the tan-
gent fields. A 31 mm circle is drawn on a central
plane, at breast mid-separation, in air, at the superior
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to extend the fluence boundary to a larger distance in
order to make enough space for skin flash in the future,
since the fluence matrix in Eclipse software has a spatial
boundary near any structure with a lower constraint. For
comparison purposes, the same delimitation of structures
was used both for CBR and TB-IMRT.
Planning technique
CBR was planned using wedged half beam blocked me-
dial and lateral tangents with 6MV only or mixed with
18MV. The collimator angle is set off 90° to allow for
use of enhanced dynamic wedging. When needed, sub-
fields were used to minimize hot spots. Our TB-IMRT
technique employed four half beam block fields with a
collimator angle off 0°, to allow for the multileaf collima-
tor to provide the optimal modulation. (The standard
tangent beam arrangement used for CBR was used for
TB-IMRT to minimize procedural change). Independent
of dose prescription, two of the fields were modulated
with 6 MV, while the other two fields remained open
and utilized 6 or 18 MV. Fluence was generated with a
dynamic multileaf collimator using Varian Millenium
(sliding window technique) with 40 leafs of 0.5 cm width
in the centre of the field and 40 leafs of 1 cm width in
the outer region of the field.
Inverse optimization for TB-IMRT
Two optimization templates were created with a script in-
corporated into the planning system (one for all fields with
6 MV and another for an unmodulated field with 18 MV
energies). This defines the dose constraints for inverse
planning. Values in the constraints within these 2 tem-
plates were adjusted if a different dose fractionation was
used using a ratio of the 2 prescriptions. Calculations were
done using the Eclipse analytical anisotropic algorithm
version 10.0. Inverse optimization was used and each
optimization used 30 iterations. Due to beam separation,
we optimized the process and found that if the 6 MV tem-
plate was used, one optimization was required, while the
18 MV template required two optimizations. The 18 MV
template was used only when dose criteria were not met
with the 6 MV template due to having three 18 MV ma-
chines only. Objectives were added to TVedit and to the
skin flash structure only. The skin flash structure had 0
priority, allowing the fluence matrix to be extended with-
out adding additional fluence there. No constraints were
added to organs at risk.
Treatment planning objectives and delivery
For each patient, the clinically used CBR plan was used.
For TB-IMRT plans, objectives were based on the follow-
ing criteria: at least 95% of the TVeval must be covered by
95% of the prescription, maximum dose must be less than107% of the prescribed dose (107% is acceptable but must
be less than 1.8 cc) while a point dose up to 110% is
allowed, and mean TVeval dose should be 100%. Mini-
mum dose should be 90%, but may be lower superficially.
Treatment delivery was done on a Cl 21iX, Trilogy Linear
Accelerator (Varian Medical Systems, Palo Alto, CA). The
fluence patterns were manually extended from approxi-
mately the inside edge of the TV to beyond the skin sur-
face using a 31 mm circle, to account for respiratory
motion and variability in day-to-day setup.
Compared to CBR, TB-IMRT was a complete planning
process change for our department. Our purpose was to
ensure that each planning step be as standard as pos-
sible. Independent of the level of expertise of the plan-
ner, as long as he follows the detailed planning
procedure, the plan should meet the planning goals. The
TB-IMRT template thus includes three components:
contouring, beam arrangements and optimization.Plan comparison parameters and statistics
For the purpose of this study, homogeneity and conform-
ity, as well as mean and maximum dose were calculated
for TVeval. The TV homogeneity index (HI) was defined
as: HI = (D2% - D98%)/Dmedian [10]. where Dmedian is the
median dose to the TV, D2% and D98% are the maximum
and minimum dose that covers 2% and 98% volume of the
PTV on dose volume histogram [10]. The conformity
index (CI) was calculated as CI = (VTpres/VT) x (VTpres/
Vpres) = V2Tpres/(VT x Vpres ) where VTpres is the target
volume covered by the 95% isodose line, Vpres is the treated
volume covered by the 95% isodose line and VT is the vol-
ume of target [11].
While they are not routinely contoured for TB-IMRT
at our center, for dose-distribution analysis, ipsilateral
and contralateral lungs, heart and contralateral breast
were additionally contoured. Heart was contoured from
its apex to the origin of the pulmonary arteries, exclud-
ing the pericardial fat and descending artery. The same
anatomical landmarks used for ipsilateral breast TV
determination were used for the contralateral breast.
Normal tissues treated were compared on the basis of
volume of ipsilateral lung receiving 5 Gy and 20 Gy or
greater (V5 and V20, respectively); contralateral lung
receiving 0.5 Gy and 5 Gy or greater (V0.5 and V5,
respectively); volume of heart receiving 1 Gy, 5 Gy
and 25 Gy (V1, V5 and V25, respectively); and volume
of contralateral breast receiving 1 and 5 Gy (V1 and
V5, respectively). A TV was delineated retrospectively
on CBR plans, as well as aforementioned normal tissue
structures for plan comparisons. Timing of each CBR
plan for workload impact evaluation did not include
time to contour these structures. Timing of each TB-
IMRT plan included time to contour structures needed
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between CBR and TB-IMRT were made using the
paired t test (two-sided) for each parameter. Statistical
comparisons were performed using Statistica (version
7.1) (StatSoft, Tulsa, OK). Results were considered sig-
nificant for p-values below 0.05.Workload impact
The following parameters were used to determine the
impact of both the CBR and TB-IMRT treatment tech-
niques on resources: time to plan (time for dosimetry
planning for CBR and for TB-IMRT time for contouring
of structures and plan optimization), time to deliver
treatment and time to perform quality assurance. Time
to plan for CBR was evaluated by the dosimetrist
assigned to the plan, while TB-IMRT plans were timed
and generated by the same individual (SKAN). Treat-
ment delivery time was evaluated in the same 20 pa-
tients with CBR plans who had actual treatments carried
out. In addition, treatment delivery time was measured
in another set of patients who had breast plans carried
out with a TB-IMRT technique. Treatment delivery time
did not include port films or other image guidance.
For both CBR and TB-IMRT plans, IMSURE QA™
Software was used for patient-specific quality assurance
(QA) for the clinic cases. Patient-specific QA was
performed using an in-house program, Epidose, for the
20 TB-IMRT plans [12]. Epidose uses portal images to
reconstruct a 3D dose distribution in a phantom and
compares this to the dose distribution generated by the
treatment planning system.Results
Workload impact
For the 20 patients planned, best CBR plans took an
average 39.0 min to be produced (15–70). For TB-IMRT
plans, structure contouring to determine TV took an
average 6.5 min (2.9-10.2). Planning time then took an
average 7.7 min (4.8-11.5). In total, TB-IMRT plans were
done in 14.0 min (7.9-19.4), which was less than CBR
planning time (14.0 vs 39.0 min, p < 0.001). 15 patients
with CBR needed 18 MV and 11 of these were planned
successfully with IMRT using only 6 MV. The average
total beam-on time for these 20 patients with CBR plans
were similar to another set of 20 patients with TB-IMRT
plans (6.0 vs 7.8 min, p = 0.13).
For the 20 patients in which Epidose QA was
performed all 20 of the TB-IMRT plans had 90% agree-
ment of points comparisons between the reconstructed
3D dose distribution in a phantom using 3% dose and
3 mm position tolerances. The generated plan thus
passed the patient QA dose test.Target volume coverage
Comparison of planning target volume and dose to or-
gans at risk parameters between TB-IMRT and CBR for
the 20 patients is shown in Table 1. TB-IMRT provided
better homogeneity index (0.096 vs 0.124, p < 0.001,
with ideal value 0) and conformity index (0.68 vs 0.59,
p = 0.003, with ideal value 1). Maximal and mean dose
were similar between TB-IMRT and CBR plans.
Normal tissue irradiation
Volume of ipsilateral lung receiving 20 Gy (V20- ipsilat-
eral lung), and volume of heart receiving 25 Gy (V25-
heart) were similar between CBR and IMRT plans.
There is a trend for higher V5-ipsilateral lung with
IMRT (22.2% vs 20.3%, p = 0.08) and IMRT yielded
plans with lower V0.5-contralateral lung (4.67% vs
10.3%, p = 0.006), lower V1-heart (33.5% vs 39.1%,
p = 0.006) and lower V1-contralateral breast (1.4% vs
6.2%, p = 0.0003).
Discussion
Breast TB-IMRT resulted in faster planning and similar
treatment time compared to CBR. TB-IMRT also permit-
ted less use of high energy beams, useful in departments
with predominance of monoenergy linacs. Furthermore,
TB-IMRT plans improved homogeneity and conformity
indices and yielded similar or better dose-volume histo-
grams for lung and heart receiving a high dose.
In order to validate our technique, dose-volume histo-
grams were generated between CBR and TB-IMRT plans
for comparison. All of our TB-IMRT plans showed im-
proved coverage and homogeneity with similar or better
parameters for organs at risk, consistent with previously
published data [4,5,13]. Randomized trials of IMRT ver-
sus non-IMRT techniques for breast cancer have
reported that improved plans can, in turn, correlate with
a decrease in acute and chronic skin toxicity, including
moist desquamation, fibrosis and late changes on
cosmesis [6,7,14]. Some plans in those studies were done
using a forward-planned IMRT technique. Some have
suggested better target homogeneity with inverse-
planned over forward-planned breast IMRT [15]. We
aimed to put into a template a less labour-intensive
technique which is less dependent on the planner’s
experience. Thus, inverse optimization with minimal
objectives and without constraints was favoured. In our
study, planning time for TB-IMRT was significantly
shorter compared to CBR. While varying IMRT tech-
niques have been reported, some have also used two
open fields with segments of IMRT within the same tan-
gential fields to function as compensators to reduce
treatment planning time [3,5,13,16-19].
Planning and delivery times are usually reported as a me-
dian or average value or as an approximation, with few
Table 1 Plan comparison parameters* between TB-IMRT and CBR techniques
Structure Parameters TB-IMRT CBR p value †
TV CI 0.68 (0.083) 0.59 (0.15) 0.003
HI 0.096 (1.2) 0.13 (2.2) < 0.001
Mean dose (%) 100.4 (0.80) 99.8 (2.6) 0.37
Maximal dose (%) 106.7 (0.85) 106.3 (0.97) 0.12
Ipsilateral lung V5 (%) 22.2 (8.0) 20.3 (8.2) 0.09
V20 (%) 12.5 (5.0) 12.9 (5.2) 0.41
Contralateral lung V0.5 (%) 4.7 (8.1) 10.3 (9.5) 0.006
V5 (%) Negligible Negligible NS
Heart V1 (%) 33.5 (2.2) 39.1 (21) 0.006
V5 (%) 4.91 (6.5) 4.7 (5.1) 0.67
V25 (%) 2.2 (3.8) 2.2 (2.5) 0.32
Contralateral breast V1 (%) 1.4 (2.1) 6.2 (4.4) 0.0003
V5 (%) Negligeable Negligeable NS
Abbreviations: D2% and D98% are the maximum and minimum dose that covers 2% and 98% volume of the PTV on dose volume histogram; TB-IMRT = template-
based intensity-modulated radiation therapy; NS = non significant; TV = treated volume; Vn (5) = percent volume receiving n Gy or greater.
*Average values (standard deviation) for the 20 patients.
† Two-sided paired t test.
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using semi-automated methods and use of an optimization
volume as the target objective [18]. Goals were achieved in
61 patients with 2 conventional open and 2 IMRT tangents,
similar to our technique. Total planning time was on aver-
age 10 min. Mayo et al. compared dose-volume histograms
for five techniques for 10 breast patients: CBR, forward-
planned field-in-field IMRT, IMRT only tangents, conven-
tional open plus IMRT tangents similar to our technique,
and finally, conventional open plus IMRT tangents with 2
anterior oblique IMRT beams [13]. The conventional open
plus IMRT tangents (what they term “hybrid-IMRT”)
achieved the best dose distribution, and was similar to
field-in-field IMRT yet required only approximately 15 min
to optimize. These authors used normal tissue contouring
(e.g., lung and heart) and delineation of a breast CTV,
which required additional effort from both the physician
and dosimetrist. However, they stated that it took less than
10 min to define breast CTV after some experience, al-
though this learning curve time was not specified in the re-
port. In Fong et al.’s planning study, comparisons between
several IMRT techniques and CBR were performed. With-
out mentioning specific times, they stated that tangential
beam IMRT was less difficult and less time consuming than
multi-field IMRT [17]. Descovich et al. investigated the
planning efficiency of direct aperture optimization IMRT
(where the delivery parameters, such as number of seg-
ments, shapes and weights are directly considered during
optimization) versus forward planning IMRT using two
tangential beams for whole breast [16]. Forward planning
took 60–90 min, increasing to 3–5 h for a less experi-
enced planner. Direct aperture optimization IMRT took
20–30 min to generate.A source of weakness in this study which could have af-
fected measurements, was that time to plan for CBR was
measured by the dosimetrist assigned to the plan, while
TB-IMRT plans were timed and generated by the same in-
dividual (SKAN). Nevertheless, while our dosimetrists are
experienced in CBR planning, TB-IMRT was a new plan-
ning technique in our department. Interestingly, there was
an almost non-existent learning curve for TB-IMRT plans
contoured and optimized by the same individual. In
addition, since it was not feasible to compare treatment
times between CBR and TB-IMRT in the same set of pa-
tients, we used another set of 20 patients who were
planned using TB-IMRT for treatment time comparisons.
This might also have affected measurements, although
both set of patients had comparable characteristics.
Our planners now use templates for breast TB-IMRT
to replace CBR, with predetermined parameters for
optimization, to obtain desired fluence patterns and
beam weighting for each individual patient. The use of
templates to facilitate IMRT planning for increased effi-
ciency has been published for other disease sites
[20,21]. To our knowledge, we are the first to docu-
ment the use of templates for inverse planning breast
IMRT. Contouring only what was necessary for plan-
ning can be done easily, and when parameters are set
in advance into a template, optimization can become
less labour intensive. Our TB-IMRT technique avoided
unnecessary time spent contouring structures for in-
verse optimization. We found small, albeit statistically
significant improvements in some parameters, such as
lower dose to contralateral lung, heart and contralateral
breast, with a trend to lower dose to ipsilateral lung.
This is likely to be of little clinical significance, and
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ard for TB-IMRT of the breast in our department.
Applying a template for inverse optimization permits
IMRT use, yet is less dependent on the planner’s experi-
ence with dose optimization. The learning trajectory for
implementing TB-IMRT is very short, and the same soft-
ware tools with no additional hardware can also be used.
TB-IMRT allowed a significant (11 out of 15) number of
plans to be done using 6 MV only, permitting transfer to
underutilized single energy accelerators. Also, neutron
background is eliminated if only 6 MV photons can be
used alone without higher energy photons. Equal treatment
times between TB-IMRT and CBR do not affect treatment
workload and patient convenience. Finally, since there is
no increase in time for plan QA, physicist workload would
not suffer. Taken together, these findings support imple-
mentation of TB-IMRT in our department, and can easily
be transferable to other departments as well.
Conclusions
TB-IMRT provided reduction of planning time and use of
high energy beams, with similar treatment times and equal
or better plans compared to CBR. This technique permits
rational use of resources with a low learning curve, and
can be done with existing equipment and personnel.
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